SG11202111993SA - Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitors - Google Patents
Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitorsInfo
- Publication number
- SG11202111993SA SG11202111993SA SG11202111993SA SG11202111993SA SG11202111993SA SG 11202111993S A SG11202111993S A SG 11202111993SA SG 11202111993S A SG11202111993S A SG 11202111993SA SG 11202111993S A SG11202111993S A SG 11202111993SA SG 11202111993S A SG11202111993S A SG 11202111993SA
- Authority
- SG
- Singapore
- Prior art keywords
- structural formula
- compound represented
- conditions suitable
- produce
- iii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962841649P | 2019-05-01 | 2019-05-01 | |
| PCT/US2020/031124 WO2020223678A1 (en) | 2019-05-01 | 2020-05-01 | Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202111993SA true SG11202111993SA (en) | 2021-11-29 |
Family
ID=70802955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202111993SA SG11202111993SA (en) | 2019-05-01 | 2020-05-01 | Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitors |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12479806B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3962898A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7630444B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220004142A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114040909B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020266170B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021021706A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3135712A1 (cg-RX-API-DMAC7.html) |
| CR (1) | CR20210590A (cg-RX-API-DMAC7.html) |
| IL (1) | IL287673B1 (cg-RX-API-DMAC7.html) |
| MA (1) | MA55808A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021013211A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202111993SA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020223678A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114040909B (zh) | 2019-05-01 | 2025-06-03 | 卡尔约药物治疗公司 | 用于制备xpo1抑制剂以及用于制备xp01抑制剂的中间体的方法 |
| JP2021048976A (ja) * | 2019-09-24 | 2021-04-01 | 株式会社ユニバーサルエンターテインメント | 遊技機 |
| CN112679477B (zh) * | 2020-12-17 | 2021-10-26 | 佛山奕安赛医药科技有限公司 | 塞利尼索及其中间体的制备方法 |
| CN116514773B (zh) * | 2023-04-24 | 2024-12-03 | 重庆汉佩生物科技有限公司 | 一种Verdinexor(KPT-335)及其盐酸盐的合成方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2542089B1 (en) | 2010-03-05 | 2017-01-18 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
| EP2665362B1 (en) | 2011-01-17 | 2016-03-30 | Karyopharm Therapeutics, Inc. | Olefin containing nuclear transport modulators and uses thereof |
| EP4234545A3 (en) | 2011-07-29 | 2023-09-06 | Karyopharm Therapeutics Inc. | Hydrazide containing nuclear transport modulators and uses thereof |
| JP6006794B2 (ja) | 2011-07-29 | 2016-10-12 | カリオファーム セラピューティクス，インコーポレイテッド | 核内輸送調節因子およびその使用 |
| WO2013170068A2 (en) * | 2012-05-09 | 2013-11-14 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
| EP2968278B8 (en) | 2013-03-15 | 2019-05-22 | Karyopharm Therapeutics Inc. | Methods of promoting wound healing using crm1 inhibitors |
| WO2014205393A1 (en) | 2013-06-21 | 2014-12-24 | Karyopharm Therapeutics Inc. | Nuclear transport modulators and uses thereof |
| ME03421B (me) | 2013-06-21 | 2020-01-20 | Karyopharm Therapeutics Inc | 1,2,4-triazoli kao modulatori nuklearnog transporta i njihova upotreba |
| KR102608259B1 (ko) | 2014-08-15 | 2023-11-29 | 카리오팜 쎄라퓨틱스, 인코포레이티드 | 셀리넥소의 다형태 |
| US10526295B2 (en) | 2015-12-31 | 2020-01-07 | Karyopharm Therapeutics Inc. | Nuclear transport modulators and uses thereof |
| EP3397634A1 (en) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
| WO2017118940A1 (en) * | 2016-01-08 | 2017-07-13 | Dr. Reddy's Laboratories Limited | Solid forms of selinexor and process for their preparation |
| EP3565813A1 (en) * | 2017-01-05 | 2019-11-13 | Watson Laboratories, Inc. | Novel crystalline forms of selinexor and process for their preparation |
| CN114040909B (zh) | 2019-05-01 | 2025-06-03 | 卡尔约药物治疗公司 | 用于制备xpo1抑制剂以及用于制备xp01抑制剂的中间体的方法 |
-
2020
- 2020-05-01 CN CN202080048243.6A patent/CN114040909B/zh active Active
- 2020-05-01 AU AU2020266170A patent/AU2020266170B2/en active Active
- 2020-05-01 SG SG11202111993SA patent/SG11202111993SA/en unknown
- 2020-05-01 BR BR112021021706A patent/BR112021021706A2/pt unknown
- 2020-05-01 MX MX2021013211A patent/MX2021013211A/es unknown
- 2020-05-01 WO PCT/US2020/031124 patent/WO2020223678A1/en not_active Ceased
- 2020-05-01 CA CA3135712A patent/CA3135712A1/en active Pending
- 2020-05-01 MA MA055808A patent/MA55808A/fr unknown
- 2020-05-01 US US17/607,670 patent/US12479806B2/en active Active
- 2020-05-01 CR CR20210590A patent/CR20210590A/es unknown
- 2020-05-01 KR KR1020217038842A patent/KR20220004142A/ko active Pending
- 2020-05-01 JP JP2021564434A patent/JP7630444B2/ja active Active
- 2020-05-01 EP EP20727786.4A patent/EP3962898A1/en active Pending
-
2021
- 2021-10-28 IL IL287673A patent/IL287673B1/en unknown
-
2025
- 2025-02-04 JP JP2025016855A patent/JP7850834B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020266170A1 (en) | 2021-11-25 |
| US20220242832A1 (en) | 2022-08-04 |
| CR20210590A (es) | 2022-03-11 |
| JP2025072490A (ja) | 2025-05-09 |
| JP2022531576A (ja) | 2022-07-07 |
| JP7850834B2 (ja) | 2026-04-23 |
| CA3135712A1 (en) | 2020-11-05 |
| WO2020223678A1 (en) | 2020-11-05 |
| US12479806B2 (en) | 2025-11-25 |
| MX2021013211A (es) | 2022-03-11 |
| IL287673B1 (en) | 2026-01-01 |
| EP3962898A1 (en) | 2022-03-09 |
| MA55808A (fr) | 2022-03-09 |
| JP7630444B2 (ja) | 2025-02-17 |
| CN114040909A (zh) | 2022-02-11 |
| IL287673A (en) | 2021-12-01 |
| BR112021021706A2 (pt) | 2022-04-19 |
| KR20220004142A (ko) | 2022-01-11 |
| AU2020266170B2 (en) | 2026-02-26 |
| CN114040909B (zh) | 2025-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020266170B2 (en) | Process for preparing XPO1 inhibitors and intermediates for use in the preparation of XP01 inhibitors | |
| EP3645518B1 (en) | Synthesis of omecamtiv mecarbil | |
| PH12014501160B1 (en) | Method for producing substituted 5-fluoro-1h - pyrazolopyridines | |
| JP6873053B2 (ja) | タンパク質脱アセチル化阻害剤の製造方法 | |
| CN111499640A (zh) | 哌嗪并三唑类衍生物的手性拆分方法 | |
| KR102550845B1 (ko) | α-할로-아크릴산 유도체의 전이 금속-촉매 프로토탈카복실화 | |
| JP2013537534A (ja) | 化合物ｏｓｉ−９０６の調製のためのプロセス | |
| JP2021515018A (ja) | 可溶性グアニル酸シクラーゼ刺激薬を調製するための方法 | |
| CN117402163A (zh) | 一种磷酸芦可替尼杂质的制备方法 | |
| WO2013001457A1 (en) | Novel salts of sitagliptin | |
| JP2009525964A (ja) | ６，７−ジヒドロ−５Ｈ−イミダゾ［１，２−ａ］イミダゾール−３−スルホン酸アミドの合成 | |
| WO2012035554A1 (en) | An improved process for the preparation of highly pure paliperidone | |
| WO2010082110A2 (en) | Novel process for preparing pure 6-fluoro-3-piperidin-4-yl-1,2-benzisoxazole hydrochloride and its conversion to paliperidone | |
| CN101263128B (zh) | 1,2-苯并异噁唑-3-乙酸的磺化方法 | |
| WO2024224298A1 (ko) | 4-아미노인단의 제조 방법 및 디하이드로인데닐-피라졸로[3,4-b]피리딘 아민 화합물의 제조 방법 | |
| CN115368283A (zh) | 一种手性结构或非手性结构的顺式-3-氟-4-羟基吡咯烷及其衍生物的制备方法 | |
| EA052667B1 (ru) | Синтез дироксимелфумарата | |
| WO2024251276A1 (zh) | 氧代吡啶类化合物的新型制备方法及关键中间体和应用 | |
| JP4520145B2 (ja) | ３−スピロ［シクロヘキサン−１，３’−［３ｈ］インドリン］−２’−オン誘導体の調製のための方法 | |
| HK40068051B (en) | Synthesis of omecamtiv mecarbil | |
| HK40025477A (en) | Synthesis of omecamtiv mecarbil | |
| HK40025477B (en) | Synthesis of omecamtiv mecarbil | |
| JPWO2000078722A1 (ja) | 医薬品中間体化合物の製造方法 | |
| JP2012197254A (ja) | ベンジル２−ハロエチルカルバメートの製造方法 |